| For: | Sun HJ, Jiao B, Wang Y, Zhang YH, Chen G, Wang ZX, Zhao H, Xie Q, Song XH. Necroptosis contributes to non-alcoholic fatty liver disease pathoetiology with promising diagnostic and therapeutic functions. World J Gastroenterol 2024; 30(14): 1968-1981 [PMID: 38681120 DOI: 10.3748/wjg.v30.i14.1968] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v30/i14/1968.htm |
| Number | Citing Articles |
| 1 |
Zhuoheng Li, Juan Li, Shuli He, Jun Chen, Chengjun Deng, Jintao Duan. Ellagic Acid Modulates Necroptosis, Autophagy, Inflammations, and Stress to Ameliorate Nonalcoholic Liver Fatty Disease in a Rat Model. Food Science & Nutrition 2025; 13(1) doi: 10.1002/fsn3.4694
|
| 2 |
Dae Won Jun, Eileen L Yoon, Ju Hee Oh, Seung Min Lee, Hye Young Kim, In Young Kang, Ji Eun Kim, Jae Eun Ryu, Gye Ryeol Park, Hyun Sung Kim, Han-Ning Xuan Yuan. Adenosine triphosphate-binding pocket inhibitor for mixed lineage kinase domain-like protein attenuated alcoholic liver disease <i>via</i> necroptosis-independent pathway. World Journal of Gastroenterology 2025; 31(6): 96782 doi: 10.3748/wjg.v31.i6.96782
|
| 3 |
Meng Zhang, Mingzhao Jia, Yinan Liu, Yawen Shi, Xu Zhao, Chen Chen, Jinghong Chen. RIPK3/MLKL-mediated necroptosis promotes hepatic inflammation in chronic arsenic exposure through drinking water. Food and Chemical Toxicology 2026; 211 doi: 10.1016/j.fct.2026.116020
|
| 4 |
Zamza Khairullina, Saulesh Kurmangaliyeva, Rustam Yussupov, Elmira Kelimberdiyeva, Liliya Tryfonyuk, Nasriddin Shapambayev, Aizat Seidakhmetova, Talgat Medetbekov, Anton Tkachenko. Pesticides Drive Liver Diseases Through Non-Apoptotic Regulated Cell Death Pathways. Diseases 2026; 14(3) doi: 10.3390/diseases14030096
|
| 5 |
Jiaenli Bolati, Ahequeli Gemingnuer, Fang Lu, Yueqi Yan, Donghua Yu, Chunmiao Yu. Metabolic syndrome necroptosis: disease implications and therapeutic targeting. Journal of Physiology and Biochemistry 2026; 82(1) doi: 10.1007/s13105-026-01161-7
|
| 6 |
Qian Liu, Puyuan Hu, Yingying Tan, Tong Wu, Liming Chen, Zheng Wang, Jingfeng Yang. Cardiovascular–kidney–metabolic syndrome and targeted therapeutic strategies. Genes & Diseases 2026; doi: 10.1016/j.gendis.2026.102160
|
| 7 |
Moses New-Aaron, Lukman A. Adepoju, Anup Singh Pathania, Kusum K. Kharbanda, Natalia A. Osna. Hepatocyte-Derived Apoptotic Bodies as Pathological Intercellular Messengers in the Liver. Biomolecules 2026; 16(2) doi: 10.3390/biom16020198
|
| 8 |
Yidong Jin, Han Zhang, Min Zhou, Shaojun Zhang, Mi Guo. Alteration of Serum MLKL Levels and Their Association with Severity and Clinical Outcomes in Human Severe Traumatic Brain Injury: A Prospective Cohort Study. International Journal of General Medicine 2024; doi: 10.2147/IJGM.S485153
|
| 9 |
Chunfeng Lu, Yu Zhang, Jingrong Miao, Wei Wei, Yang Wang, Yiwen Han, Yuanyuan Li, Ye Tong, Tianle Wang, Xiaofeng Bao. Inhibition of ZFP281/ZNF281–RIPK1/RIPK3/MLKL signaling in hepatocytes by pterostilbene relieves hepatic lipometabolic disorder and inflammation in non-alcoholic steatohepatitis. International Immunopharmacology 2025; 146 doi: 10.1016/j.intimp.2024.113936
|
| 10 |
Wenjing Song, Zhifei Ke. Targeting necroptosis: how does exercise protect against metabolic dysfunction-associated fatty liver disease?. Frontiers in Physiology 2026; 17 doi: 10.3389/fphys.2026.1760364
|
| 11 |
Marwa Matboli, Maha Saad, Manar Fouad Ahmed, Amany Helmy Hasanin, Ghada M. Ellithy, Marian Samir Abdelwahab, Eman Hamdy Badr Eltantawy, Ghada Galal Hamam, Amany E. Hamoud, Marwa M. El-Shafei, Nehal samir. Febuxostat alleviate metabolic dysfunction-associated steatohepatitis in rat model via targeting inflammation, cell death, and intestinal barrier dysfunction. Biomedicine & Pharmacotherapy 2025; 187 doi: 10.1016/j.biopha.2025.118086
|
| 12 |
Mei-Ling Chang, Jia-Hui Cai, Tzu-Chieh Hsu, Yen-Tzu Tseng, I-Hsuan Liu, Prisca-Maryla Henheik. Triterpenoid‐Enriched Bitter Melon Leaf Extract Mitigates Hepatic Lipotoxicity and Necroptosis in Diet‐Induced Obese Zebrafish. Journal of Food Biochemistry 2026; 2026(1) doi: 10.1155/jfbc/3734609
|
| 13 |
Jianxin Xi, Shuangyin Lei, Jie Chen, Jiahui Liu, Chenhao Shan, Xun Sun, Qianqian Zheng, Xiaoju Shi. Killing hepatocellular carcinoma in the NAFLD/NASH stage: a comprehensive perspective on targeting regulated cell death. Cell Death Discovery 2025; 11(1) doi: 10.1038/s41420-025-02558-x
|
| 14 |
Hui-li Xu, Sheng-rong Wan, Ying An, Qi Wu, Yi-hang Xing, Chen-hao Deng, Ping-ping Zhang, Yang Long, Bu-tuo Xu, Zong-zhe Jiang. Targeting cell death in NAFLD: mechanisms and targeted therapies. Cell Death Discovery 2024; 10(1) doi: 10.1038/s41420-024-02168-z
|